Summary

Eligibility
for people ages up to 22 years (full criteria)
Location
at UCSF
Dates
study started
completion around

Description

Summary

Details

Keywords

Hemophagocytic Lymphohistiocytosis, Newly Diagnosed, Frontline therapy, Refractory, Relapsed, Response-adapted, Salvage therapy, Dexamethasone, Etoposide, Etoposide phosphate, Ruxolitinib

Eligibility

Locations

  • University of California San Francisco
    San Francisco California 94158 United States
  • Children's Hospital of Orange County
    Orange California 92868 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
St. Jude Children's Research Hospital
Links
St. Jude Children's Research Hospital ClinicalTrials Open at St. Jude
ID
NCT04551131
Phase
Phase 1/2 Hemophagocytic Lymphohistiocytosis Research Study
Study Type
Interventional
Participants
About 10 people participating
Last Updated